Loss of consciousness during G-CSF treatment [2];Perte de connaissance au cours d'un traitement par G-CSF [2]

Revue de Medecine Interne

Volumn 18, Issue 10, 1997, Pages 822-823

  Peyrade, F ^a   Lebrun, C ^a   De Jaureguiberry, J P ^b   Taillan, B ^a   Jaubert, D ^b   Dujardin, P ^a  

^a University of Côte d'Azur   (France)

^b Military Teaching Hospital Sainte Anne   (France)

Author keywords

Hematopoietic growth factor; Lost of consciousness; Seizures

Indexed keywords

CISPLATIN; DOXORUBICIN; HEMOPOIETIC GROWTH FACTOR; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE;

AGED; BLADDER TUMOR; CASE REPORT; CONSCIOUSNESS DISORDER; HUMAN; LETTER; LIVER METASTASIS; MALE; SEIZURE;

EID: 0030765485     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(97)89976-6     Document Type: Letter

References (3)

1. Vose JM, Armitage JO. Clinical applications of hematopoïetic growth factor. J Clin Oncol 1995;13:1023-35
2. Cannistra SA, Dicarlo J, Groshek P, Kanakura Y, Griffin JD. Simultaneous administration of GM-CSF and cytosine arabinoside for the treatment of relapsed acute myeloïd leukemia. Leukemia 1991;5:230-8
3. Magrath IT, Adde M, Shad A et al. A new short duration chemotherapy protocol for the treatment of small non-cleaved cell and large cell lymphomas. Proc Am Soc Clin Oncol 1993;12:385